​

Pasithea Therapeutics (KTTA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Pasithea Therapeutics Revenue Highlights

00

Pasithea Therapeutics Revenue by Period

Pasithea Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$486.56K3130.37%
2021-12-31$15.06K100.00%
2020-12-31--

Pasithea Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Pasithea Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$976.31K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$240.71K10.11%
2022-09-30$218.61K1509.66%
2022-06-30$13.58K-0.56%
2022-03-31$13.66K-9.32%
2021-12-31$15.06K100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-09-30--

Pasithea Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Pasithea Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KZRKezar Life Sciences$7.00M-
KRONKronos Bio$6.29M$2.37M
MNOVMediciNova$1.00M-
ABVCABVC BioPharma$152.43K$117.14K
VRAXVirax Biolabs Group$8.56K$76.50K
FBRXForte Biosciences--
REVBRevelation Biosciences--
RNXTRenovoRx--
INDPIndaptus Therapeutics--
QNRXQuoin Pharmaceuticals--
KPRXKiora Pharmaceuticals--
KTTAPasithea Therapeutics--

KTTA Revenue FAQ

What is Pasithea Therapeutics’s yearly revenue?

Pasithea Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $486.56K, representing an increase of 3130.37% compared to 2021. KTTA's yearly revenue for 2021 was $15.06K, representing an increase of 100.00% compared to 2020.

What is Pasithea Therapeutics’s quarterly revenue?

Pasithea Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). KTTA's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Pasithea Therapeutics’s revenue growth rate?

Pasithea Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%